Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
AVADEL Pharmaceuticals Plc (AVDL)  
$15.99 0.00 (0.00%) as of 4:30 Fri 4/12


Download
   
Exchange: Nasdaq National Market
Security Type: ADR
Shares Out: 58,240,000
Market Cap: 931.26(M)
Last Volume: 115,349 Avg Vol: 115,030
52 Week Range: $9.64 - $17.22
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Delivery

Member Indexes:

    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Avadel Pharmaceuticals is a biopharmaceutical company. Co.'s primary product candidate, FT218, is an investigational once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in narcolepsy patients. Co.'s commercial products are: Akovaz, which is indicated for the treatment of hypotension occurring in the setting of anesthesia; Bloxiverz, which is indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery; and Vazculep®, which is for the treatment of hypotension occuring in the setting of anesthesia; and Nouress, which is a sterile injectable product for use in the hospital setting.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 2,000 41,000 370,500
Total Buy Value $0 $29,000 $558,597 $1,422,084
Total People Bought 0 1 4 6
Total Buy Transactions 0 1 5 18
Total Shares Sold 0 75,000 103,975 103,975
Total Sell Value $0 $1,089,750 $1,522,364 $1,522,364
Total People Sold 0 1 1 1
Total Sell Transactions 0 1 2 2
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 186
  Page 7 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Elrod Marcus W See Remarks   •       –      –    2016-12-14 4 A $0.00 $0 D/D 18,000 58,000     -
   Hatten Sandra L See Remarks   •       –      –    2016-12-14 4 A $0.00 $0 D/D 18,000 58,000     -
   Kanan Michael F See Remarks   •       –      –    2016-12-14 4 A $0.00 $0 D/D 18,000 58,000     -
   Monteith David See Remarks   •       –      –    2016-12-14 4 A $0.00 $0 D/D 18,000 58,000     -
   Sullivan Stephen G. See Remarks   •       –      –    2016-12-14 4 A $0.00 $0 D/D 18,000 58,000     -
   Thompson Phillandas T. See Remarks   •       –      –    2016-12-14 4 A $0.00 $0 D/D 18,000 58,000     -
   Stapleton Craig R Director   –       •      –    2016-11-29 4 B $10.85 $108,500 I/I 10,000 40,000 2.1     -
   Stapleton Craig R Director   –       •      –    2016-11-28 4 B $10.74 $107,370 I/I 10,000 30,000 2.1     -
   Anderson Michael S Chief Executive Officer   •       •      –    2016-11-21 4 B $10.64 $21,274 D/D 2,000 193,250 2.81     -
   Fildes Francis Director   –       •      –    2016-09-22 4 S $13.45 $201,750 D/D (15,000) 15,000     -
   Anderson Michael S Chief Executive Officer   •       •      –    2016-09-02 4 B $14.12 $28,240 D/D 2,000 191,250 2.81     -
   Stapleton Craig R Director   –       •      –    2016-09-01 4 B $13.52 $135,190 D/D 10,000 519,678 2.39     -
   Stapleton Craig R Director   –       •      –    2016-08-26 4 B $13.67 $275,140 I/I 20,000 20,000 2.1     -
   Anderson Michael S Chief Executive Officer   •       •      –    2016-08-22 4 B $14.30 $71,479 D/D 5,000 189,250 2.81     -
   Anderson Michael S Chief Executive Officer   •       •      –    2016-08-10 4 A $0.00 $0 D/D 50,000 184,250     -
   Macke Scott A. See Remarks   •       –      –    2016-08-10 4 A $0.00 $0 D/D 15,000 42,000     -
   Davis Gregory J. See Remarks   •       –      –    2016-08-10 4 A $0.00 $0 D/D 20,000 20,000     -
   Thompson Phillandas T. See Remarks   •       –      –    2016-08-10 4 A $0.00 $0 D/D 20,000 40,000     -
   Monteith David See Remarks   •       –      –    2016-08-10 4 A $0.00 $0 D/D 15,000 17,500     -
   Hatten Sandra L See Remarks   •       –      –    2016-08-10 4 A $0.00 $0 D/D 20,000 23,000     -
   Stapleton Craig R Director   –       •      –    2016-05-16 4 B $9.25 $22,339 D/D 2,415 509,678 2.39     -
   Stapleton Craig R Director   –       •      –    2016-05-13 4 B $9.21 $228,553 D/D 24,813 507,263 2.39     -
   Anderson Michael S Chief Executive Officer   •       •      –    2016-05-12 4 B $8.84 $44,200 D/D 5,000 134,250 2.81     -
   Thompson Phillandas T. See Remarks   •       –      –    2016-03-22 4 B $11.10 $111,030 D/D 10,000 20,000 2.74     -
   Anderson Michael S Chief Executive Officer   •       •      –    2016-03-18 4 B $11.04 $55,220 D/D 5,000 129,250 2.81     -

  186 Records found
  1  2  3  4  5  6  7  8   
  Page 7 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed